Ebrahim Azizi

4.1k total citations · 1 hit paper
101 papers, 3.3k citations indexed

About

Ebrahim Azizi is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Ebrahim Azizi has authored 101 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 35 papers in Molecular Biology and 24 papers in Biomedical Engineering. Recurrent topics in Ebrahim Azizi's work include Cancer Cells and Metastasis (26 papers), Cancer Genomics and Diagnostics (11 papers) and Microfluidic and Bio-sensing Technologies (10 papers). Ebrahim Azizi is often cited by papers focused on Cancer Cells and Metastasis (26 papers), Cancer Genomics and Diagnostics (11 papers) and Microfluidic and Bio-sensing Technologies (10 papers). Ebrahim Azizi collaborates with scholars based in Iran, United States and Canada. Ebrahim Azizi's co-authors include Shamileh Fouladdel, Max S. Wicha, Sunitha Nagrath, Diane M. Simeone, Seyed Nasser Ostad, Mohammad Abdollahı, Nithya Ramnath, Hyeun Joong Yoon, Jules Lin and Tae Hyun Kim and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Ebrahim Azizi

90 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets

2013 462 citations Hyeun Joong Yoon, Tae Hyun Kim et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ebrahim Azizi Iran	28	1.1k	1.1k	935	626	393	101	3.3k
Anne Corlu France	35	640 0.6×	1.6k 1.5×	828 0.9×	395 0.6×	148 0.4×	100	4.3k
Yusuf Baran Türkiye	33	644 0.6×	2.2k 2.0×	402 0.4×	420 0.7×	225 0.6×	106	4.1k
Renata Kontek Poland	23	723 0.6×	1.4k 1.3×	417 0.4×	391 0.6×	360 0.9×	74	3.3k
Stefania Meschini Italy	31	619 0.5×	1.4k 1.3×	238 0.3×	409 0.7×	146 0.4×	81	2.9k
Anna Rita Cappello Italy	34	478 0.4×	1.9k 1.7×	323 0.3×	679 1.1×	327 0.8×	93	3.6k
Takahiro Seki Japan	30	695 0.6×	2.5k 2.3×	439 0.5×	735 1.2×	153 0.4×	59	4.8k
Huanjie Yang China	32	721 0.6×	2.0k 1.9×	420 0.4×	505 0.8×	107 0.3×	57	3.8k
Xin Meng China	34	463 0.4×	2.7k 2.5×	938 1.0×	547 0.9×	177 0.5×	159	4.7k
Zhonghu Bai China	23	712 0.6×	2.1k 1.9×	420 0.4×	664 1.1×	196 0.5×	105	3.4k
Marco Cordani Spain	26	486 0.4×	1.1k 1.1×	668 0.7×	459 0.7×	122 0.3×	72	3.0k

Countries citing papers authored by Ebrahim Azizi

Since Specialization

Citations

This map shows the geographic impact of Ebrahim Azizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebrahim Azizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebrahim Azizi more than expected).

Fields of papers citing papers by Ebrahim Azizi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebrahim Azizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebrahim Azizi. The network helps show where Ebrahim Azizi may publish in the future.

Co-authorship network of co-authors of Ebrahim Azizi

This figure shows the co-authorship network connecting the top 25 collaborators of Ebrahim Azizi. A scholar is included among the top collaborators of Ebrahim Azizi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebrahim Azizi. Ebrahim Azizi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Azizi, Ebrahim, Shahriar Mostufa, Bahareh Rezaei, et al.. (2025). Applying stochastic Langevin function with coupled Brownian–Néel relaxations to study the dynamic magnetizations of nanoparticle tracers in magnetic particle imaging. Journal of Physics D Applied Physics. 58(13). 135002–135002. 1 indexed citations

Azizi, Ebrahim, Changzhi Li, Jenifer Gómez‐Pastora, Rui He, & Kai Wu. (2025). Effects of excitation field amplitude on magnetic particle imaging performance: a modeling study. Journal of Physics D Applied Physics. 58(30). 305002–305002.

Mostufa, Shahriar, Bahareh Rezaei, Ebrahim Azizi, et al.. (2025). Characterizing the physicochemical properties of magnetic nanoparticles by a surface plasmon resonance approach. AIP Advances. 15(3). 1 indexed citations

Karampelas, Ioannis, Arjun Sharma, Shahriar Mostufa, et al.. (2024). Additive Manufacturing of Magnetic Materials for Energy, Environment, Healthcare, and Industry Applications. Advanced Functional Materials. 35(10). 3 indexed citations

Tay, Zhi Wei, Shahriar Mostufa, Ebrahim Azizi, et al.. (2024). Magnetic nanoparticles for magnetic particle imaging (MPI): design and applications. Nanoscale. 16(25). 11802–11824. 17 indexed citations

Zibara, Kazem, et al.. (2021). A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism. Thrombosis Journal. 19(1). 74–74. 3 indexed citations

Azizi, Ebrahim, et al.. (2021). The prognostic importance of BCR-ABL transcripts in Chronic Myeloid Leukemia: A systematic review and meta-analysis. Leukemia Research. 101. 106512–106512. 17 indexed citations

Zibara, Kazem, et al.. (2021). Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients. Molecular Cytogenetics. 14(1). 24–24. 5 indexed citations

Javar, Hamid Akbari, et al.. (2020). Notice of Retraction: Preparation and characterization of crosslinked and non-crosslinked polycaprolactone fumarate (PCLF) NPs as carriers for doxorubicin HCl. African Journal of Pharmacy and Pharmacology. 14(10). 377.

10.

Azizi, Ebrahim, et al.. (2019). Iranian patients with hemoglobin H disease: genotype–phenotype correlation. Molecular Biology Reports. 46(5). 5041–5048. 6 indexed citations

11.

Wang, Yang, Tae Hyun Kim, Shamileh Fouladdel, et al.. (2019). PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer. Scientific Reports. 9(1). 566–566. 104 indexed citations

12.

Murlidhar, Vasudha, Rishindra M. Reddy, Shamileh Fouladdel, et al.. (2017). Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers. Cancer Research. 77(18). 5194–5206. 139 indexed citations

13.

Yoon, Hyeun Joong, Tae Hyun Kim, Zhuo Zhang, et al.. (2013). Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets. Nature Nanotechnology. 8(10). 735–741. 462 indexed citations breakdown →

14.

Mohseni, Mehran, et al.. (2012). Study on Acute and Subchronic Toxicity, Cytotoxicity and In Vitro Developmental Toxicity of Safflower Extracts of “IL 111” and “LRV 51 51” Cultivars. Iranian journal of pharmaceutical sciences. 8(1). 343–352. 1 indexed citations

15.

Khalili, Hossein, et al.. (2011). Association of N-Acetyltransferase-2 Genotypes and Anti-Tuberculosis Induced Liver Injury: First Case-Controlled Study from Iran. Current Drug Safety. 6(1). 17–22. 20 indexed citations

16.

Fouladdel, Shamileh, Ali Khalaj, Neda Adibpour, & Ebrahim Azizi. (2010). Synthesis and cytotoxicity of some biurets against human breast cancer T47D cell line. Bioorganic & Medicinal Chemistry Letters. 20(19). 5772–5775. 10 indexed citations

17.

Zarghi, Afshin, et al.. (2009). Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry. 17(14). 5312–5317. 57 indexed citations

18.

Ostad, Seyed Nasser, Mohammad Sharifzadeh, Ebrahim Azizi, & Abbas Kebriaeezadeh. (2006). LEAD EXPOSURE IMPAIRS NMDA AGONIST-INDUCED NO PRODUCTION IN PYRAMIDAL HIPPOCAMPAL CELLS. DARU Journal of Pharmaceutical Sciences. 14(1). 44–50. 1 indexed citations

19.

Azizi, Ebrahim, et al.. (2004). CROSS-RESISTANCE TO VINCRISTIN AND ETOPOSIDE IN A SUB LINE OF THE HUMAN BREAST CANCER T47D CELLS SELECTED FOR ADRIAMYCIN-RESISTANCE. Iranian journal of pharmaceutical research. 3(2). 103–107. 1 indexed citations

20.

Azizi, Ebrahim, et al.. (2003). The Inhibitory Effects of Ascorbic Acid, α-Tocopherol, and Sodium Selenite on Proliferation of Breast Cancer Cell Lines. Iranian journal of pharmaceutical research. 2(3). 173–177. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact